Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) As a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2024 Sep 17

PMID 39286031

Authors

Philippa Randall

Junior Mutsvangwa

Marriott Nliwasa

Lindsay Wilson

Beauty Makamure

Edson Makambwa

Richard Meldau

Keertan Dheda

Shungu Munyati

Omar Siddiqi

Elizabeth Corbett

Ali Esmail

Affiliations

Soon will be listed here.

Abstract

Background: Tuberculous meningitis (TBM) mortality is high and current diagnostics perform suboptimally. We evaluated the diagnostic performance of a DNA-based assay (GeneXpert Ultra) against a new same-day immunodiagnostic assay that detects unstimulated interferon-gamma (IRISA-TB).

Methods: In a stage 1 evaluation, IRISA-TB was evaluated in biobanked samples from Zambia (n = 82; tuberculosis [TB] and non-TBM), and specificity in a South African biobank (n = 291; non-TBM only). Given encouraging results, a stage 2 evaluation was performed in suspected TBM patients from Zimbabwe and Malawi (n = 668). Patients were classified as having definite, probable or possible TBM, or non-TBM based on their microbiological results, cerebrospinal fluid (CSF) chemistry, and whether they received treatment.

Results: In the stage 1 evaluation, sensitivity and specificity of IRISA-TB were 75% and 87% in the Zambian samples, and specificity was 100% in the South African samples. In the stage 2 validation, IRISA-TB sensitivity (95% confidence interval [CI]) was significantly higher than Xpert Ultra (76.2% [55.0%-89.4%] vs 25% [8.9%-53.3%]; = .0048) when trace readouts were considered negative. Specificity (95% CI) was similar for both assays (91.4% [88.8%-93.4%] vs 86.9% [83.4%-89.8%]). When the Xpert Ultra polymerase chain reaction product was verified by sequencing, the positive predictive value of trace readouts in CSF was 27.8%. Sensitivity of IRISA-TB was higher in human immunodeficiency virus (HIV)-infected versus uninfected participants (85.8% vs 66.7%).

Conclusions: As a same-day rule-in test, IRISA-TB had significantly better sensitivity than Xpert Ultra in a TB/HIV-endemic setting. An immunodiagnostic approach to TBM is promising, and further studies are warranted.

References

Dheda K, van Zyl-Smit R, Sechi L, Badri M, Meldau R, Meldau S . Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis. Eur Respir J. 2009; 34(5):1118-26. DOI: 10.1183/09031936.00005309. View

Dodd P, Osman M, Cresswell F, Stadelman A, Lan N, Thuong N . The global burden of tuberculous meningitis in adults: A modelling study. PLOS Glob Public Health. 2023; 1(12):e0000069. PMC: 10021871. DOI: 10.1371/journal.pgph.0000069. View

Chilukutu L, Mwanza W, Kerkhoff A, Somwe P, Kagujje M, Muyoyeta M . Prevalence and interpretation of Xpert Ultra trace results among presumptive TB patients. Public Health Action. 2022; 12(1):28-33. PMC: 8908867. DOI: 10.5588/pha.21.0066. View

Shi F, Qiu X, Yu M, Huang Y . Tuberculosis-specific antigen stimulated and unstimulated interferon-γ for tuberculous meningitis diagnosis: A systematic review and meta-analysis. PLoS One. 2022; 17(8):e0273834. PMC: 9426936. DOI: 10.1371/journal.pone.0273834. View

Bahr N, Meintjes G, Boulware D . Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. J Med Microbiol. 2019; 68(5):755-760. PMC: 7176281. DOI: 10.1099/jmm.0.000975. View

Dheda K, Van-Zyl Smit R, Sechi L, Badri M, Meldau R, Symons G . Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One. 2009; 4(3):e4689. PMC: 2650091. DOI: 10.1371/journal.pone.0004689. View

Patel V, Singh R, Connolly C, Kasprowicz V, Zumla A, Ndungu T . Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS One. 2011; 5(12):e15664. PMC: 3008727. DOI: 10.1371/journal.pone.0015664. View

Shen Y, Yu G, Zhao W, Lang Y . Efficacy of Xpert MTB/RIF Ultra in diagnosing tuberculosis meningitis: A systematic review and meta-analysis. Medicine (Baltimore). 2021; 100(29):e26778. PMC: 8294889. DOI: 10.1097/MD.0000000000026778. View

Meldau R, Peter J, Theron G, Calligaro G, Allwood B, Symons G . Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study. BMC Pulm Med. 2014; 14:58. PMC: 4108018. DOI: 10.1186/1471-2466-14-58. View

10.

Donovan J, Thu D, Phu N, Dung V, Quang T, Nghia H . Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis. 2020; 20(3):299-307. PMC: 7045088. DOI: 10.1016/S1473-3099(19)30649-8. View

11.

Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger C, Schumacher S . Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. 2018; 8:CD012768. PMC: 6513199. DOI: 10.1002/14651858.CD012768.pub2. View

12.

Huang M, Wang G, Sun Q, Jiang G, Li W, Ding Z . Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China. Diagn Microbiol Infect Dis. 2021; 100(1):115306. DOI: 10.1016/j.diagmicrobio.2020.115306. View

13.

Cao W, Leng E, Liu S, Zhou Y, Luo C, Xiang Z . Recent advances in microbiological and molecular biological detection techniques of tuberculous meningitis. Front Microbiol. 2023; 14:1202752. PMC: 10494440. DOI: 10.3389/fmicb.2023.1202752. View

14.

Aggarwal A, Agarwal R, Sehgal I, Dhooria S . Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis. PLoS One. 2019; 14(3):e0213728. PMC: 6435228. DOI: 10.1371/journal.pone.0213728. View

15.

Pooran A, Randall P, Meldau R, Maine R, Esmail A . Economic evaluation of microbiological and host biomarker-based tests for the diagnosis of pleural tuberculosis in a high burden setting. J Thorac Dis. 2022; 14(9):3167-3177. PMC: 9562520. DOI: 10.21037/jtd-22-106. View

16.

Esmail A, Tomasicchio M, Meldau R, Makambwa E, Dheda K . Comparison of Xpert MTB/RIF (G4) and Xpert Ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting. Int J Infect Dis. 2020; 95:246-252. DOI: 10.1016/j.ijid.2020.03.025. View

17.

Cresswell F, Tugume L, Bahr N, Kwizera R, Bangdiwala A, Musubire A . Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. Lancet Infect Dis. 2020; 20(3):308-317. PMC: 7045085. DOI: 10.1016/S1473-3099(19)30550-X. View

18.

Levinson S, Miller J . Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta. 2002; 325(1-2):1-15. DOI: 10.1016/s0009-8981(02)00275-9. View

19.

Dheda K, van Zyl-Smit R, Meldau R, Meldau S, Symons G, Khalfey H . Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax. 2009; 64(10):847-53. DOI: 10.1136/thx.2009.116376. View

20.

Kimuda S, Kasozi D, Namombwe S, Gakuru J, Mugabi T, Kagimu E . Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis. Curr HIV/AIDS Rep. 2023; 20(6):379-393. PMC: 10719136. DOI: 10.1007/s11904-023-00678-6. View